Updates

September 20, 2019September 20, 2019
FDA OKs Use of Tool to Predict Patient Response to New Form of Cisplatin in Planned Phase 3 Study

The U.S. Food and Drug Administration (FDA) has approved use of a device, called LiPlaCis DRP, that works to predict response to the next-generation investigational ... Read more
September 18, 2019
Herceptin Developers Granted 2019 Lasker-DeBakey Research Award

The 2019 Lasker-DeBakey Clinical Medical Research Award has been granted to scientists H. Michael Shepard, PhD, Dennis J. Slamon, MD, PhD, and Axel Ullrich, PhD, for ... Read more
September 16, 2019
TNBC Patient Given Investigative Antibody, Leronlimab, Under Emergency Exception

A metastatic triple-negative breast cancer (TNBC) patient is being treated with CytoDyn’s investigational leronlimab (PRO 140) under an emergency investigational new drug (IND) application ... Read more
September 13, 2019September 13, 2019
FDA to Review Nerlynx Combo as Third-line Treatment for HER2-positive Metastatic Breast Cancer

The U.S. Food and Drug Administration (FDA) has agreed to review Puma Biotechnology’s application seeking approval of Nerlynx (neratinib), in combination with capecitabine, to treat ... Read more
September 11, 2019
Music Helps Ease Pain and Fatigue of Breast Cancer, Study Shows

Listening to music at home can considerably ease the severity of symptoms related to breast cancer and its treatments, helping reduce the pain and fatigue ... Read more

A Lump in the Road - A Column by Nancy Brier, Columns

Cancer by the Numbers
September 10, 2019September 5, 2019
1: Number of times a doctor told me, “Best-case scenario, you’ll be stuck with ...
News

Nerlynx Granted FDA’s Orphan Drug Status for Treating Breast Cancer with Brain Metastases
September 9, 2019September 9, 2019
The U.S. Food and Drug Administration (FDA) has granted orphan drug status to Puma Biotechnology’s Nerlynx (neratinib) for ...
News

Longer Use of Hormone Replacement Therapy Linked to Greater Breast Cancer Risk in Study
September 6, 2019
The longer women use hormone therapy after menopause the higher is their breast cancer ...
News

FDA Urges Inclusion of Men in Clinical Trials for Breast Cancer Treatment
September 4, 2019
The U.S. Food and Drug Administration (FDA) has drafted a series of recommendations urging ...
News

Tecentriq-Abraxane Combo OK’d in EU to Treat Certain Advanced Triple-negative Breast Cancers
August 30, 2019
The European Commission has approved the use of Roche‘s Tecentriq (atezolizumab) in combination with Abraxane (nab-paclitaxel) ...
News

USPSTF Updates Recommendations on Testing for BRCA-related Cancers in Women
August 28, 2019
The United States Preventive Services Task Force (USPSTF) has revised their recommendations on testing ...

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

10 Commandments for Surviving Breast Cancer
August 27, 2019August 22, 2019
I hate giving advice, but I’ve learned lessons through my breast cancer journey that ...
Grant to Fund CAR T-cell Trial for HER2-Positive BC with Brain Metastases
August 26, 2019September 18, 2019
The California Institute for Regenerative Medicine (CIRM) has granted a $9.28 million award to ...
Oral Paclitaxel Combo Leads to Better Response Rates Than IV Therapy in MBC, Data Shows
August 23, 2019August 23, 2019
FDA Approves Rozlytrek for Breast Cancer, Other Solid Tumors with Specific Gene Defect
August 21, 2019
Phase 2 Trial of NeuVax Vaccine for HER2-positive DCIS Fully Enrolled, Sellas Announces
August 19, 2019
Trial Testing Eftilagimod Alpha-Chemo Combo for HR-positive Advanced Breast Cancers Now Fully Enrolled
August 16, 2019

Eagle Prepares Clinical Trials of New Form of Fulvestrant to Treat ER-positive Breast Cancer
August 14, 2019
Eagle Pharmaceuticals is preparing a pilot study that may pave the way for a ...
‘Chemopause’: Too Hot to Trot
August 13, 2019August 9, 2019
Fujifilm’s New Imaging Option Can Enhance Accuracy of Breast Biopsy
August 12, 2019August 26, 2019
Test Being Developed to Determine Risk of Recurrence in Triple-negative Breast Cancer
August 9, 2019

Keytruda Plus Chemo Increases Percentage of TNBC Patients With No Cancer Signs, Interim Analysis Shows
August 7, 2019September 10, 2019
Using Keytruda (pembrolizumab) in combination with chemotherapy increased the percentage of patients showing no ...
First Generic Version of Navelbine Launched in Europe for Breast, Lung Cancers
August 5, 2019September 10, 2019
Verzenio-Faslodex Combo Prolongs Survival in Advanced Breast Cancer, Interim Phase 3 Data Show
August 2, 2019

News

Team Will Use $10K Award to Bring Anti-lymphedema Bra to Market
July 31, 2019August 26, 2019
A team of recent University of Iowa (UI) graduates who designed a bra to ...
News

Anixa Partners with Cleveland Clinic to Take Breast Cancer Vaccine to Human Trials
July 29, 2019July 29, 2019
Anixa Biosciences, a leading company developing anti-cancer immunotherapies, is partnering with the Cleveland Clinic ...
News

FDA Approves Clinical Testing of Minerva’s CAR T-cell Therapy for Metastatic BC
July 26, 2019
Minerva Biotechnologies will soon start the first human trials testing its investigational therapy huMNC2-CAR44, ...
News

Combining Breast, Lung Cancer Therapies Could Overcome Treatment Resistance
July 24, 2019
Combining Ibrance (palbociclib), a treatment for advanced breast cancer, with the lung cancer medicine crizotinib is ...
A Lump in the Road - A Column by Nancy Brier, Columns

Breast Cancer? Put It on Ice
July 23, 2019July 17, 2019
The bad news? It was cancer. The good news? It was in the early ...
News

Antibody-Drug Conjugate Shows Efficacy in Heavily Treated Cancers
July 22, 2019
An investigational antibody-drug conjugate made of the HER2-targeting antibody trastuzumab (marketed as Herceptin and ...
News

Genomic Analysis Reveals Differences Between Cancer Cell Lines and Human Cancers
July 19, 2019
New research using “big data” helps highlight the differences between breast cancer cell lines ...
News

Trilaciclib-Chemo Combo Extends Lives of Triple-negative Breast Cancer Patients, Preliminary Phase 2 Findings Show
July 17, 2019
Trilaciclib, a treatment that protects the bone marrow from the damaging effects of chemotherapy, ...
A Lump in the Road - A Column by Nancy Brier, Columns

What Cancer Taught Me About Being a Mom
July 16, 2019July 11, 2019
I dated a guy in college who described the time he saw a nasty ...
News

$20M Gift to Dana-Farber Will Establish Fund for Metastatic Breast Cancer Research
July 15, 2019July 15, 2019
The Dana-Farber Cancer Institute will get $20 million to create the Saverin Breast Cancer ...
News

Balixafortide-Halaven Combo Seen to Prolong Survival in Advanced Breast Cancer Patients in Phase 1 Trial
July 12, 2019July 12, 2019
A combination of Polyphor‘s investigational therapy balixafortide (POL6326) and Eisai‘s Halaven (eribulin) may prolong the ...
News

Obesity Reprograms Immune Cells in Mammary Tissues to Promote Tumor Development, Study Says
July 10, 2019
Obesity in women with triple-negative breast cancer, the most aggressive kind of breast cancer, ...
News

Puma Applies to FDA to Extend Nerlynx’s Use to HER2-Positive Metastatic Breast Cancer
July 8, 2019
Puma Biotechnology is seeking to extend the use of its breast cancer medicine Nerlynx ...
News

CHMP Recommends Tecentriq-Abraxane Combination to Treat Some Triple-negative Breast Cancers in Europe
July 3, 2019
The  Committee for Medicinal Products for Human Use (CHMP),  an arm of the  European Medicines Agency , ...
A Lump in the Road - A Column by Nancy Brier, Columns

Survival Is All About the Money
July 2, 2019June 27, 2019
“It’s cancer,” my friend said. She had seen a doctor for something unrelated, but ...
News

Fujifilm Bus Hits the Road to Offer Breast Cancer Screenings and Promote Early Diagnosis
July 1, 2019July 1, 2019
Fujifilm Medical Systems USA has launched a nationwide effort to enhance access to breast ...
News

Breast Cancer Index Identifies Patients Who Will Benefit From Extended Endocrine Therapy, Data Shows
June 28, 2019
Biotheranostics‘ Breast Cancer Index can help distinguish which breast cancer patients will derive a ...
News

European Commission Approves Talzenna to Treat Some Breast Cancers
June 26, 2019
The European Commission (EC) has approved Pfizer‘s Talzenna (talazoparib) for the treatment of patients ...

June 22, 2018June 22, 2018

Clinical Trial of Tamoxifen-based Gel in Reducing Breast Density Recruiting in US, EU

News

The ability of a gel containing a tamoxifen-byproduct to reduce breast density — associated with an increased risk of breast cancer — is now being evaluated in a recruiting Phase 3 clinical trial. Approximately half of women in ... Read more

Subscribe to our mailing list

Pin It on Pinterest